Market Tracker

05/25 5:15pm ET

Celgene Corp (NASDAQ:CELG)

78.63
Delayed Data
As of May 25
 -0.91 / -1.14%
Today’s Change
74.13
Today|||52-Week Range
147.17
-24.66%
Year-to-Date
Agios (AGIO) Progressing Well on Pipeline Amid Competition
May 24 / Zacks.com - Paid Partner Content
Main Small-Cap Index Russell 2000 Rallies to Record
May 21 / GuruFocus News - Paid Partner Content
bluebird's Lenti-D Gets Breakthrough Therapy Status From FDA
May 24 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close79.54
Today’s open79.41
Day’s range78.34 - 79.56
Volume6,128,107
Average volume (3 months)7,628,942
Market cap$61.8B
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)+46.18%
Earnings growth (this year)+14.82%
Earnings growth (next 5 years)+16.85%
Revenue growth (last year)+17.40%
P/E ratio21.9
Price/Sales6.58
Price/Book9.36

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.08+0.15%
GSKGlaxoSmithKline-0.18-0.45%
ABBVAbbVie-2.06-2.00%
SNYSanofi-0.36-0.93%
Data as of 4:02pm ET, 05/25/2018

Financials

Next reporting dateJuly 26, 2018
EPS forecast (this quarter)$2.11
Annual revenue (last year)$12.8B
Annual profit (last year)$2.9B
Net profit margin22.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
COO
Mark J. Alles
Executive VP, Chief Financial &
Accounting Officer
Peter N. Kellogg
Corporate headquarters
Summit, New Jersey

Forecasts